Assessment
encorafenib
Metastatic colorectal cancer (mCRC) with BRAF-V600E mutation after prior systemic therapy
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relationsAssessment
Metastatic colorectal cancer (mCRC) with BRAF-V600E mutation after prior systemic therapy
Connected evidence
2 relations